Paul Chinn
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 8
- Radiopharmaceutical Chemistry and Applications 7
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Nabil Hanna (5 shared papers)Nimisha Deb (2 shared papers)Susan J. Knox (2 shared papers)Michael L. Goris (2 shared papers)Kirk Trisler (2 shared papers)Antonio J Grillo-López (2 shared papers)Mark Becker (2 shared papers)Carol Marquez (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)Clinical Cancer Research (1 paper)International Journal of Oncology (1 paper)Cancer Biotherapy and Radiopharmaceuticals (1 paper)Blood (1 paper)
- Partner nations
- United StatesMexicoSwitzerland
In The Last Decade
Paul Chinn
11 papers receiving 505 citations
Peers
Comparison fields: 5 of 53
- Radiology, Nuclear Medicine and Imaging 322
- Pathology and Forensic Medicine 213
- Genetics 50
- Oncology 118
- Chemical Health and Safety 3
Countries citing papers authored by Paul Chinn
This map shows the geographic impact of Paul Chinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Chinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Chinn more than expected).
Fields of papers citing papers by Paul Chinn
This network shows the impact of papers produced by Paul Chinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Chinn. The network helps show where Paul Chinn may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Chinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. | 1996 | 273 |
| 2 | 1999 | 71 | |
| 3 | 2009 | 47 | |
| 4 | 2000 | 41 | |
| 5 | 2011 | 37 | |
| 6 | 2003 | 30 | |
| 7 | 2006 | 12 | |
| 8 | 2009 | 11 | |
| 9 | 1995 | 6 | |
| 10 | 2004 | 2 | |
| 11 | 1998 | 2 |
About Paul Chinn
Paul Chinn is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Biomaterials, having authored 11 papers that have together received 532 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (2 papers), Glycosylation and Glycoproteins Research (1 paper), Immune Cell Function and Interaction (1 paper), T-cell and B-cell Immunology (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (322 citations), Pathology and Forensic Medicine (213 citations), Genetics (50 citations), Oncology (118 citations) and Chemical Health and Safety (3 citations). Paul Chinn has collaborated with scholars based in United States, Mexico and Switzerland. Frequent co-authors include Nabil Hanna, Nimisha Deb, Susan J. Knox, Michael L. Goris, Kirk Trisler, Antonio J Grillo-López, Mark Becker, Carol Marquez, Robert S. Negrin and Thomas A. Davis. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, International Journal of Oncology, Cancer Biotherapy and Radiopharmaceuticals and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.